RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis

This is the authors' accepted manuscript of an article that has been published in its final definitive form by European Respiratory Society, 2018.

For re-use rights please refer to the publisher's terms and conditions.

Author(s): Aksamit T, De Soyza A, Bandel T-J, Criollo M, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R

Publication type: Article

Publication status: Published

Journal: European Respiratory Journal

Year: 2018

Volume: 51

Issue: 1

Online publication date: 25/01/2018

Acceptance date: 20/01/2017

Date deposited: 16/03/2018

ISSN (print): 0903-1936

ISSN (electronic): 1399-3003

Publisher: European Respiratory Society

URL: https://doi.org/10.1183/13993003.02053-2017

DOI: 10.1183/13993003.02053-2017

PubMed id: 29371384

Altmetrics provided by Altmetric

Funder reference	Funder name
	MRC

ePrints